These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 4297948)
21. [Hypotensive effect of dihydrolycorine]. Chen BY; Du ZH; Zeng FD; Hu CJ; Ma GE; Hong SH Zhongguo Yao Li Xue Bao; 1993 Jan; 14(1):45-9. PubMed ID: 8503287 [TBL] [Abstract][Full Text] [Related]
22. Interaction of beta-adrenergic blocking agents with noradrenaline in vascular smooth muscle. Mazurkiewicz-Kwilecki IM Eur J Pharmacol; 1970 Jul; 11(2):155-62. PubMed ID: 4317567 [No Abstract] [Full Text] [Related]
23. A new pressor agent of renal origin: its differentiation from renin and angiotensin. Grollman A; Krishnamurty VS Am J Physiol; 1971 Nov; 221(5):1499-506. PubMed ID: 4330896 [No Abstract] [Full Text] [Related]
24. In vitro studies on the mode of action of pinacidil. Weston AH; Bray KM; Duty S; McHarg AD; Newgreen DT; Southerton JS Drugs; 1988; 36 Suppl 7():10-28. PubMed ID: 2855517 [TBL] [Abstract][Full Text] [Related]
30. New insights into the mechanisms of the vasorelaxant effects of apocynin in rat thoracic aorta. Senejoux F; Girard-Thernier C; Berthelot A; Bévalot F; Demougeot C Fundam Clin Pharmacol; 2013 Jun; 27(3):262-70. PubMed ID: 22233502 [TBL] [Abstract][Full Text] [Related]
31. Metabolism of angiotensin II and some analogs in intact strips and in muscle preparations of rabbit aortae. Magnan J; Regoli D Can J Physiol Pharmacol; 1978 Feb; 56(1):39-47. PubMed ID: 638855 [No Abstract] [Full Text] [Related]
32. [Mechanism of action of angiotensin on smooth muscles]. Worcel M J Urol Nephrol (Paris); 1974 Dec; 80(12):975-7. PubMed ID: 4376568 [No Abstract] [Full Text] [Related]
33. Differential effects of substrate depletion on drug-induced contractions of rabbit aorta. Altura BM; Altura BT Am J Physiol; 1970 Dec; 219(6):1698-705. PubMed ID: 4320911 [No Abstract] [Full Text] [Related]
34. Potent alpha-adrenoceptor action of soterenol on vascular and other smooth muscle. Kitagawa H; Yamauchi A; Shibata S Eur J Pharmacol; 1975 Aug; 33(1):227-30. PubMed ID: 240730 [TBL] [Abstract][Full Text] [Related]
35. Effects of prolactin on the responses of rat aortic and arteriolar smooth-muscle preparations to noradrenaline and angiotensin. Manku MS; Nassar BA; Horrobin DF Lancet; 1973 Nov; 302(7836):991-4. PubMed ID: 4127278 [No Abstract] [Full Text] [Related]
36. A new short-acting antagonist of angiotensin II. Türker RK; Yamamoto M; Bumpus FM Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):162-9. PubMed ID: 4352152 [No Abstract] [Full Text] [Related]
37. Contraction velocity analysis of norepinephrine and angiotensin-II activation of vascular smooth muscle. Watkins RW; Davidson IW Eur J Pharmacol; 1980 Mar; 62(2-3):177-89. PubMed ID: 7379840 [TBL] [Abstract][Full Text] [Related]
38. Effects of inorganic anions on the contractility of vascular smooth muscle. Jhamandas KH; Nash CW Can J Physiol Pharmacol; 1967 Jul; 45(4):675-82. PubMed ID: 6035985 [No Abstract] [Full Text] [Related]
39. Metamizol acts as an ATP sensitive potassium channel opener to inhibit the contracting response induced by angiotensin II but not to norepinephrine in rat thoracic aorta smooth muscle. Valenzuela F; García-Saisó S; Lemini C; Ramírez-Solares R; Vidrio H; Mendoza-Fernández V Vascul Pharmacol; 2005 Aug; 43(2):120-7. PubMed ID: 15958287 [TBL] [Abstract][Full Text] [Related]